A previous study suggested that Cinacalcet can be used as an add-on therapy for IBD to reduce production of the cytokines interferon-γ, IL-1α, and TNFα in the colon of dextran sulfate sodium (DSS)-induced colitis BALB/c mice (Elajnaf et al., 2019). The gene discussed is TNF; the disease is inflammatory bowel disease.